In: Shils M, Shike M, Ross A, Caballero B, RJ C, eds
Why the combination matters: In the REDEFINE-1 trial, semaglutide alone produced 16.1% weight loss and cagrilintide alone produced 11.8%
Since it never gained FDA approval, AOD 9604 is not an active ingredient in any legally prescribed medication in the United States
I know its sickening to discard the expired b12, but taking a chance with your health isnt worth the risk of not receiving the b12 you need to recover and remain in remission
In late 2024, Zealand Pharma initiated a phase 2b randomized dose-finding obesity and T2DM + obesity clinical trial (ZUPREME-1 and ZUPREME-2) which will evaluate petrelintides efficacy and safety in individuals with obesity in a larger population ( N = 480) [116]